Rapilysin यूरोपीय संघ - रोमानियाई - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - reteplază - infarct miocardic - agenți antitrombotici - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

ACTILYSE 50 mg रोमानिया - रोमानियाई - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

actilyse 50 mg

boehringer ingelheim pharma gmbh & co. kg - germania - alteplasum - pulb.+solv. pt. sol. inj./perf. - 50mg - antitrombotice enzime